Blister Packaging has been on a growth trend over the past several years. The European market is predominantly a Blister pack model whereas in North America, the trend is to continue to dispense at the pharmacy level. Has the reality of the latest Covid pandemic altered our market approach in any way? How can your company remain competitive and cost effectively manufacture and package for entry or growth in North America?
What market segments are ideal? Is it Rx, OTC, Probiotics? What volumes make the most sense when considering the outsourcing of this service? Is there a sustainability aspect to this packaging?
During the presentation, we will show you how to evaluate all of these aspects while also highlighting different equipment that can allow for flexibility in the volumes from high speed machines that are fully serialized for the US market, to lower volume packaging solutions.
In addition, we will offer Regulatory know how on how to cost effectively ship bulk product to North America for packaging within the US and Canada.
If you are currently at capacity on certain production lines and are looking to outsource or simply augment your capacity, this is the right presentation for you. Are you currently marketing and Rx, OTC, Natural Health or Probiotic product abroad and want to enter the Canadian or US market, join us for an informative session. Are you looking for a business continuity plan for your blister packaging activities to ensure supply, we can help.
Key Learning Objectives
- Cold Form and Hot Form Blister Packaging Services and Sustainability
- How to identify and evaluate Blister Packaging CMOs
- Cost effectiveness of Blister Packaging for the North American market
- Business Continuity in a Pandemic and Post Pandemic world
Target Audience
- Director of External Manufacturing
- VP Operations
- VP Procurement
- Project Manager
- New Product Innovation
